项目名称: 长链非编码RNA n385229吸附miR-497对胰腺癌化疗耐药表型的调控作用
项目编号: No.81502051
项目类型: 青年科学基金项目
立项/批准年度: 2016
项目学科: 医药、卫生
项目作者: 徐建威
作者单位: 山东大学
项目金额: 18万元
中文摘要: 胰腺癌化疗耐药机制是目前研究的热点和难点。我们前期研究发现miR-497负向调控IGF-1R和FGFR1,参与胰腺癌化疗敏感性调控,部分成果已发表至Oncotarget杂志;生物信息学分析发现lncRNA-n385229序列上有多个miR-497种子区的结合位点,下调lncRNA-n385229,促进miR-497表达,降低IGF-1R和FGFR1的蛋白表达水平。因此,我们推测:lncRNA-n385229作为ceRNA,竞争性结合miR-497,进而调控miR-497靶基因(IGF-1R、FGFR1)的表达水平,从而参与胰腺癌化疗耐药表型的调控。本课题拟通过体内外实验探索lncRNA-n385229/miR-497/(IGF-1R、FGFR1)对胰腺癌吉西他滨化疗敏感性的调控作用及调控机制;并结合临床标本,明确lncRNA-n385229/miR-497评估化疗敏感性、及判断预后的价值。
中文关键词: 胰腺外分泌肿瘤;化疗耐药;长链非编码RNA;竞争性内源RNA;miRNA
英文摘要: Chemoresistance is one of the key and the difficult subject of pancreatic cancer research. The mechanism of drug-resistance of pancreatic cancer remains unclear. Our previous study indicated that miR-497 re-sensitized pancreatic cancer cells to gemcitabine through direct downregulation of IGF-1R and FGFR1 protein expression, which had been partly published on Oncotarget. Bioinformatic analysis revealed the putative complementary sequences for the seed region of mir-497 in lncRNA-n385229. In addition, downregulation of lncRNA-n385229 significantly increased miR-497 expression levels, decreased the protein levels of IGF-1R and FGFR1, and re-sensitized cells to gemcitabine treatment. Based on our previous studies and literatures review, we speculated that lncRNA-n385229 might be a ceRNA and acted as a miR-497 sponge to involve in regulating chemoresistance of pancreatic cancer. This study will investigate the roles and mechanisms of lncRNA-n385229/miR-497/(IGF-1R/FGFR1)axis in regulating chemoresistance of pancreatic cancer by in vitro and in vivo experiments. We will also evaluate clinical values of lncRNA-n385229/miR-497 in predicting sensitivity to chemotherapy and prognosis of pancreatic cancer patients. This study will help us further investigate the mechanisms of chemoresistance in pancreatic cancer, and provide a new molecular target for assessing chemosensitivity and reversing drug resistance.
英文关键词: Pancreatic cancer;Chemoresistance;Long non-coding RNA;Competing endogenous RNAs;miRNA